Pharmacologic inhibition of JAK-STAT signaling promotes hair growth

Sivan Harel1, Claire A Higgins1, Jane E Cerise1

  • 1Department of Dermatology, Columbia University, New York, NY 10032, USA.

Science Advances
|November 25, 2015
PubMed

Insights

Topical Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway inhibitors promote hair growth by inducing the anagen phase. This JAK-STAT inhibition strategy offers a novel approach for treating hair loss.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Stem Cell Biology

Background:

  • Hair loss often results from hair follicles failing to enter the growth (anagen) phase.
  • Existing treatments targeting anagen induction pathways have limited success.

Purpose of the Study:

  • To investigate the efficacy of Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway inhibitors in promoting hair growth.
  • To explore the role of JAK-STAT signaling in regulating hair follicle stem cell activation.

Main Methods:

  • Topical application of small-molecule JAK-STAT inhibitors on mouse and human skin.
  • Analysis of hair follicle populations, including the hair germ.
  • Assessment of cultured human dermal papilla cell inductivity.

Main Results:

  • Topical JAK-STAT inhibition rapidly induced anagen and subsequent hair growth in mouse and human skin.
  • JAK inhibition was shown to regulate key hair follicle populations.
  • Improved inductivity of human dermal papilla cells was observed under JAK inhibition.

Conclusions:

  • JAK-STAT pathway inhibition represents a promising therapeutic strategy for promoting hair growth.
  • This pathway plays a critical role in regulating hair follicle stem cell activation and the hair cycle.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K